Rebecca Green
@rebgreen.bsky.social
Drug development is my day job (not like Walter White). Dabbling in health econ @ LSE. I like politics for some reason. City dweller, but happiest in the mountains. Abortion is healthcare. Opinions are my own.
This tracks. www.independent.co.uk/space/nasa-j...
New Nasa data hints we could be living inside a black hole
Black hole cosmology suggests our entire universe formed inside a black hole from another universe
www.independent.co.uk
March 25, 2025 at 2:15 AM
This tracks. www.independent.co.uk/space/nasa-j...
Me in the national security group chat
March 25, 2025 at 12:08 AM
Me in the national security group chat
Reposted by Rebecca Green
Why is funding NIH so important? Listen to the Good News About Cancer w/ @charlesryanmd.bsky.social @mskcancercenter.bsky.social @drkarenknudsen.bsky.social & Dr. Morgans. Also amazing news about decline in lung cancer in Puerto Rico b/c of public health measures! podcasts.apple.com/us/podcast/4...
4.75 Million Lives Saved, and Counting
Podcast Episode · The Good News About Cancer · 02/11/2025 · 23m
podcasts.apple.com
February 15, 2025 at 9:37 PM
Why is funding NIH so important? Listen to the Good News About Cancer w/ @charlesryanmd.bsky.social @mskcancercenter.bsky.social @drkarenknudsen.bsky.social & Dr. Morgans. Also amazing news about decline in lung cancer in Puerto Rico b/c of public health measures! podcasts.apple.com/us/podcast/4...
Reposted by Rebecca Green
Whenever you hear someone sneer about scientific research that seems useless to them — “they’re studying the spit of lizards?!” — remind them that’s exactly how we got Ozempic.
globalnews.ca/news/9793403...
globalnews.ca/news/9793403...
How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
globalnews.ca
February 9, 2025 at 5:38 PM
Whenever you hear someone sneer about scientific research that seems useless to them — “they’re studying the spit of lizards?!” — remind them that’s exactly how we got Ozempic.
globalnews.ca/news/9793403...
globalnews.ca/news/9793403...
This millennial is going to miss avocados.
February 1, 2025 at 10:51 PM
This millennial is going to miss avocados.
“This can’t be handed off to drug companies or biotech, because they’re not interested in things that are as preclinical as a lot of the work we’re discussing here.” Precisely.
When Trump paused federal funding to all grants and loans, it plunged scientific research into chaos. Though the freeze was rescinded for some sectors, it's still in largely place for universities and research institutions. The damage will be lasting.
The Damage to Federal Medical Research Is Already Done
Clinical trials may have to be scrapped, research applications will be pushed back, and unpaid researchers will quickly leave the sector—even if the Trump administration’s funding pause is only…
wrd.cm
February 1, 2025 at 2:02 PM
“This can’t be handed off to drug companies or biotech, because they’re not interested in things that are as preclinical as a lot of the work we’re discussing here.” Precisely.
Reposted by Rebecca Green
EU medicines agency quits X & moves to Bluesky
"EMA will no longer post updates and content on X. We believe the X platform no longer suits our communication needs” the agency said in a statement
www.reuters.com/world/europe...
"EMA will no longer post updates and content on X. We believe the X platform no longer suits our communication needs” the agency said in a statement
www.reuters.com/world/europe...
EU medicines agency quits X, moves to Bluesky
The European Medicines Agency (EMA) said on Monday it would no longer post on X and would use rival Bluesky instead, becoming the latest organisation to quit a social media platform that some have criticised for its content.
www.reuters.com
January 27, 2025 at 6:36 PM
EU medicines agency quits X & moves to Bluesky
"EMA will no longer post updates and content on X. We believe the X platform no longer suits our communication needs” the agency said in a statement
www.reuters.com/world/europe...
"EMA will no longer post updates and content on X. We believe the X platform no longer suits our communication needs” the agency said in a statement
www.reuters.com/world/europe...
Reposted by Rebecca Green
Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉)
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
January 24, 2025 at 3:22 PM
Welcome immigrants from X interested in science to the friendlier skies of @bsky.app, as documented by a new @nature.com survey (but you already knew that 😉)
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
"Bluesky is much better for science. There is much less toxicity, misinformation, and distractions."
www.nature.com/articles/d41...
Reposted by Rebecca Green
Dear Colleagues, the Prostate Cancer Clinical Trials Consortium (PCCTC) is now on BlueSky. We invite you to follow us at
@thepcctc.bsky.social
Thank you for supporting our mission!
@thepcctc.bsky.social
Thank you for supporting our mission!
November 20, 2024 at 8:02 PM
Dear Colleagues, the Prostate Cancer Clinical Trials Consortium (PCCTC) is now on BlueSky. We invite you to follow us at
@thepcctc.bsky.social
Thank you for supporting our mission!
@thepcctc.bsky.social
Thank you for supporting our mission!
Reposted by Rebecca Green
Participating in the PCCTC-managed PROMISE Registry will add to our understanding of how genetic differences can affect patient outcomes, help family members understand their own risk of cancer, and guide discovery of new personalized treatments. To learn more visit www.prostatecancerpromise.org
January 14, 2025 at 4:53 PM
Participating in the PCCTC-managed PROMISE Registry will add to our understanding of how genetic differences can affect patient outcomes, help family members understand their own risk of cancer, and guide discovery of new personalized treatments. To learn more visit www.prostatecancerpromise.org
Reposted by Rebecca Green
Random shoutout to urge your organization to migrate to Bluesky if they haven't yet. Content from valid, professional sources was a huge plus to the old twitter, and more of that here will only make our experience better.
November 20, 2024 at 7:26 PM
Random shoutout to urge your organization to migrate to Bluesky if they haven't yet. Content from valid, professional sources was a huge plus to the old twitter, and more of that here will only make our experience better.
Reposted by Rebecca Green
The more I use Bluesky, the more I realize the ways Threads fumbled the ball.
Threads’ biggest mistake: not grasping that conversation-centric social media is contemporaneous.
Everyone needs to see things at the same time so they can *engage with each other at the same time*.
1/
Threads’ biggest mistake: not grasping that conversation-centric social media is contemporaneous.
Everyone needs to see things at the same time so they can *engage with each other at the same time*.
1/
November 19, 2024 at 1:28 PM
The more I use Bluesky, the more I realize the ways Threads fumbled the ball.
Threads’ biggest mistake: not grasping that conversation-centric social media is contemporaneous.
Everyone needs to see things at the same time so they can *engage with each other at the same time*.
1/
Threads’ biggest mistake: not grasping that conversation-centric social media is contemporaneous.
Everyone needs to see things at the same time so they can *engage with each other at the same time*.
1/
November 12, 2024 at 3:01 AM
Twitter (RIP) ➡️ Threads ➡️ Bluesky… how’s it going over here?
November 10, 2024 at 2:20 AM
Twitter (RIP) ➡️ Threads ➡️ Bluesky… how’s it going over here?